Cargando…
Reply to ‘Comment on ‘Nomogram to predict pathologic complete response in HER2-positive breast cancer treated with neoadjuvant systemic therapy''
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5396116/ https://www.ncbi.nlm.nih.gov/pubmed/28291772 http://dx.doi.org/10.1038/bjc.2017.61 |
| _version_ | 1783230007739416576 |
|---|---|
| author | Fujii, Takeo Ueno, Naoto T |
| author_facet | Fujii, Takeo Ueno, Naoto T |
| author_sort | Fujii, Takeo |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5396116 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | Nature Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-53961162018-04-11 Reply to ‘Comment on ‘Nomogram to predict pathologic complete response in HER2-positive breast cancer treated with neoadjuvant systemic therapy'' Fujii, Takeo Ueno, Naoto T Br J Cancer Letter to the Editor Nature Publishing Group 2017-04-11 2017-03-14 /pmc/articles/PMC5396116/ /pubmed/28291772 http://dx.doi.org/10.1038/bjc.2017.61 Text en Copyright © 2017 Cancer Research UK http://creativecommons.org/licenses/by-nc-sa/4.0/ From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 4.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ |
| spellingShingle | Letter to the Editor Fujii, Takeo Ueno, Naoto T Reply to ‘Comment on ‘Nomogram to predict pathologic complete response in HER2-positive breast cancer treated with neoadjuvant systemic therapy'' |
| title | Reply to ‘Comment on ‘Nomogram to predict pathologic complete response in HER2-positive breast cancer treated with neoadjuvant systemic therapy'' |
| title_full | Reply to ‘Comment on ‘Nomogram to predict pathologic complete response in HER2-positive breast cancer treated with neoadjuvant systemic therapy'' |
| title_fullStr | Reply to ‘Comment on ‘Nomogram to predict pathologic complete response in HER2-positive breast cancer treated with neoadjuvant systemic therapy'' |
| title_full_unstemmed | Reply to ‘Comment on ‘Nomogram to predict pathologic complete response in HER2-positive breast cancer treated with neoadjuvant systemic therapy'' |
| title_short | Reply to ‘Comment on ‘Nomogram to predict pathologic complete response in HER2-positive breast cancer treated with neoadjuvant systemic therapy'' |
| title_sort | reply to ‘comment on ‘nomogram to predict pathologic complete response in her2-positive breast cancer treated with neoadjuvant systemic therapy'' |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5396116/ https://www.ncbi.nlm.nih.gov/pubmed/28291772 http://dx.doi.org/10.1038/bjc.2017.61 |
| work_keys_str_mv | AT fujiitakeo replytocommentonnomogramtopredictpathologiccompleteresponseinher2positivebreastcancertreatedwithneoadjuvantsystemictherapy AT uenonaotot replytocommentonnomogramtopredictpathologiccompleteresponseinher2positivebreastcancertreatedwithneoadjuvantsystemictherapy |